Mesenchymal stem cells versus mesenchymal stem cells-derived exosomes as potential autophagy pathway modulators in a diabetic model

This publication has 57 references indexed in Scilit:

• Dysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023
• Pancreatic beta cell autophagy is impaired in type 1 diabetes
  Diabetologia, 2021
• The Therapeutic Potential of Extracellular Vesicles Versus Mesenchymal Stem Cells in Liver Damage
  Tissue Engineering and Regenerative Medicine, 2020
• Global trends in diabetes complications: a review of current evidence
  Diabetologia, 2018
• Immunomodulatory effects of mesenchymal stem cell–derived exosomes on experimental type‐1 autoimmune diabetes
  Journal of Cellular Biochemistry, 2018
• Abnormalities of the Exocrine Pancreas in Type 1 Diabetes
  Current Diabetes Reports, 2015
• The efficiency of in vitro isolation and myogenic differentiation of MSCs derived from adipose connective tissue, bone marrow, and skeletal muscle tissue
  In Vitro Cellular & Developmental Biology - Animal, 2012
• Bone Marrow Mesenchymal Cells: How Do They Contribute to Tissue Repair and Are They Really Stem Cells?
  Archivum Immunologiae et Therapiae Experimentalis, 2011
• Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
  Stem Cells, 2011
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001